IMPORTANT DEADLINES

Abstract Submission 11/15/07

Pre Registration 1/25/08
Hotel Reservations 2/1/08

 

IMPORTANT DATES

Meeting 2/24/08-2/27/08


BALTIMORE RESOURCES




 

 

2006



The 4th Annual ASM Biodefense Research Meeting was held February 15-18, 2006 in Washington, DC. The 2006 meeting continued the success of ASM's three previous Biodefense Meetings as an important scientific research event. This meeting brought together top scientists conducting critical research to defend against the growing threat of bioterrorism and decision makers shaping the future biodefense research agenda.

 

Wednesday, February 15, 2006
Time Session Presenters
2:00-5:00pm Focus Session 1: Microbial
Forensics

Organizers: Steven E. Schutzer, MD, University of Medicine and Dentistry (UMDNJ), New Jersey Medical School and Jacques Ravel, PhD, The Institute for Genomic Research (TIGR)


 

Real-World Investigation of Biological Crime: Combining Scientific Investigation and Traditional Forensics


Jason Bannan , PhD, Federal Bureau of Investigation

  Forensic Aspects of the Human Response to Microbial Threats: Role of the Physician and Microbiologist at the Initial Stages of a Biocrime


Steven E. Schutzer, MD, UMDNJ, New Jersey Medical School
  Preservation of Scientific Evidence Beginning at the Crime Scene

Terry Kerns, MS, Hazardous Materials Response Unit (HMRU). Federal Bureau of Investigation

 

Applying Microbiological Techniques at the Crime Scene

Douglas J. Beecher, PhD, HMRU, Federal Bureau of Investigation

  Validation of Molecular Genetic Analysis

Paul Keim, PhD, Northern Arizona University

  Keynote Lecture – The Current Status and Future of Microbial Forensics


Bruce Budowle, PhD, FBI Laboratory
  Panel Discussion - Where Do We Go from Here and How Do We Get There?

Panelists include all above speakers and Ronald M. Atlas, PhD, University of Louisville,
Jenifer Smith, PhD, FBI Laboratory, and James P. Burans, PhD, National Bioforensic Analysis Center, DHS

2:00-5:00pm

Focus Session 2

Risk and Control of Biothreat Agents in Our Drinking Water

 

Organizers:  Debra Huffman, PhD, MPH, University of South Florida and Vince Hill, PhD, PE, Centers for Disease Control

Developed in Cooperation with the Disinfection Committee of the Water Environment Federation



 

Welcome and Introductions


Debra Huffman, PhD, MPH, University of South Florida

 

Keynote Lecture - Water-Related Bioterrorism Preparedness: Overall Perspective


Kim Fox, PhD, US Environmental Protection Agency
 

A New Filtration Technique for Recovering Biothreat Agents from Drinking Water


Vince Hill, PhD, Centers for Disease Control
 

Simultaneous Detection of Environmental Pathogens Using Multiplexed PCR-Coupled Liquid Bead Array Assays


Wendy Wilson, PhD, Lawrence Livermore National Labortory
 

Chlorine and Monochloramine Inactivation of Bacterial Select Agent



Laura Rose, PhD, Centers for Disease Control
  Evaluation of Point of Use Treatment Devices for Chemical and Microbial Contamination


Robert Ferguson, PhD, National Sanitation Foundation
  Panel Disscussion and Moderated Q&A Debra Huffman, PhD, MPH, University of South Florida and all Speakers

6:00pm-8:00pm

Welcome and Opening Remarks from the ASM Biodefense Research Meeting


 

Chairperson and Vice Chairperson
Michael Buchmeier
, PhD, The Scripps Research Institute, and
Virginia Miller, PhD, Washington University

 

  Keynote Address - Biodefense and Pandemic Influenza: The Research and Public Health Interface Anthony Fauci, MD, National Institute of Allergy and Infectious Disease, National Institutes of Health

  Response to BioDisasters:  Natural and Man-Made
Panel Round Table
Moderated by
James Hughes
, MD, Emory University
Paul Keim, PhD, Northern Arizona University
Arturo Casadevall, MD, PhD, Albert Einstein College of Medicine 
Mary Gilchrist, PhD, University of Iowa
Bruce Gellin, MD, MPH, Department of Health and Human Services
Thursday, February 16, 2006
Time Session Presenters
8:00am-11:30am

Plenary Session Contemporary Vaccine Design

Moderator: Rafi Ahmed, MD, Emory University Vaccine Center

 

Welcome and Opening Remarks

Rafi Ahmed, MD, Emory University Vaccine Center

  Rapid Design of Effective Vaccines Gary J. Nabel, MD, PhD, Vaccine Research Center, NIAID, NIH

  A Roadmap for the Immunomics of Category A-C Pathogens
Alessandro Sette, PhD, La Jolla Institute for Allergy and Immunology

  Vaccination, Memory and Monkey Pox
Mark Slifka, PhD, Vaccine & Gene Therapy Institute, Oregon Health Science University

 

Can We Make Better Influenza Virus Vaccines?

Peter Palese, PhD, Mount Sinai School of Medicine

 

Panel Discussion and Q&A

 

Moderated by Rafi Ahmed, MD, Emory University Vaccine Center


1:30-2:30pm Poster Sessions  

     
3:00-5:00pm

Session T1
Understanding Viral Virulence

Moderator: Michael Bray, MD, MPH, Biodefense Clinical Research Branch, NIAID, NIH

  Poxvirus Virulence: Current Concepts
Grant McFadden, PhD, University of Western Ontario, London, Canada

  Marburg Virus, Angola, 2005: Evidence of Increased Virulence
Thomas Geisbert, PhD, Virology Division, USAMRID

  Using a Benign Virus to Thwart a Virulent One
Steven Jones, PhD, Special Pathogens Program, National Microbiology Laboratory, Health, Canada

  Pathogenesis and Treatment of Human Arenaviral Infections

Juan de la Torre, PhD, Molecular Integrative Neuroscience Department, The Scripps Research Institute

  Moderated Q&A and Wrap Up
Michael Bray, MD, MPH and all Session Speakers


3:00-5:00pm

Session T2
New Animal Models for Testing Vaccines for Select Agents


Organizer: Sam Stanley, MD, Washington University

  The NOD-SCID IL2 Receptor Gamma Chain Null Mouse Model as a Host for Human Hematopoietic Stem Cells to Generate a Functional Human Immune System


Leonard Shultz, PhD, The Jackson Laboratory
  huAIS-RG Mice - New Options to Study Human Lymphotropic Infections in vivo?
Markus Manz, MD, Institute for Research in Biomedicine


Markus Manz, MD, Institute for Research in Biomedicine
 

Humanized Mice for Development and Testing of Human Vaccines

 


Anna K. Palucka, MD, PhD, Baylor Institute for Immunology
 
Chimeric SCID-Human Mice to Study Enteric Pathogens



Sam L. Stanley, Jr., MD, Washington University
  Animal Models for the Evaluation of Anti-Orthopoxvirus Antivirals and Vaccines



Robert M. L. Buller, PhD, St. Louis University
  Moderated Q&A and Wrap Up

Sam L. Stanley, Jr, MD, and all Session Speakers


3:00-5:00pm

Concurrent Session T3
Vector, Food, and Waterborne Transmission


Organizer: Carol D. Blair, PhD, Colorado State University
  Welcome and Opening Remarks


Carol D. Blair, PhD, Colorado State University

  Yersinia pestis – Flea Interaction B. Joseph Hinnebusch, PhD, Rocky Mountain Labs, NIAID, NIH

  RNA Interference to Develop Genetically Resistant Mosquitoes
Carol D. Blair, PhD, Colorado State University

  Balanced Homeostasis at the Arthropod -Rickettsia Interface Abdu F. Azad, MD, University of Maryland School of Medicine

  Food and Waterborne Transmission of Shigella dysenteriae and Potential Preventative Strategies


Eileen M. Barry, PhD, Univ. of Maryland Sch. of Med.
  Moderated Q&A and Wrap Up
Carol Blair, PhD and all Session Speakers
Friday, February 17, 2006
Time Session Presenters
8:30am-11:30am

Plenary Session – A Role for Structural Biology in Biodefense

Moderator: R. John Collier, MD, Harvard Medical School

  Welcome & Opening Remarks
R. John Collier, PhD, Harvard Medical School

  Plenary Keynote Address Large-Scale, Rapid Proteomics of Biodefense-Related Pathogens


Peter Kuhn, PhD, The Scripps Research Institute
  Insight Into the Evolution and Animal Origins of SARS Coronavirus from Structure/Function Studies of ACE2 and the SARS Coronavirus S Protein


Michael Farzan, PhD, Harvard Medical School
  Undressing Flaviviurses to Reveal Mechanisms of Infection
Richard J. Kuhn, PhD, Purdue University

  Anthrax Toxin Receptors/Inhibitors
D. Borden Lacy, PhD, Harvard Medical School

  Structural Divergence in the Botulinum Neurotoxin Family and Therapeutic Development Adjustments

Raymond C. Stevens, PhD, The Scripps Research Institute

1:30pm–2:30pm

Poster Sessions

 

3:00-5:00pm

Concurrent Session F4 Understanding Virulence - Bacterial

Organizers: Denise Monack, PhD, Stanford University

  Welcome and Opening Remarks

Denise Monack, PhD, Stanford University

  The Brucella Type IV Secretion System and Host Response Renee Tsolis, PhD University of California, Davis

  Bacillus anthracis Capsule Expression and Virulence
Theresa Koehler, PhD University of Texas, Houston

  Cellular and Molecular Pathogenesis of Burkholderia
Edouard Galyov, PhD, Institute for Animal Health, Compton Laboratory

  Lessons from a Murine Model for Pneumonic Plague William Goldman, Washington University

  Moderated Q&A and Wrap Up Denise Monack, PhD and all Session Speakers
3:00-5:00pm    

 

Concurrent Session F5 – Diagnostics, Detection, and Pathogen Identification

Organizer: W. Ian Lipkin, MD, Columbia University

  Welcome and Opening Remarks



Ian Lipkin, MD, Columbia University
  Innovative Low-Cost Technologies for Biomedical Research and Diagnosis in Developing Countries


Eva Harris, PhD, University of California, Berkley
 

Development and Evaluation of Genomic and Proteomic Diagnostics in Acute Care Settings

 

Richard E. Rothman, MD, PhD, Johns Hopkins University & Charlotte Gaydos, Dr.PH, Johns Hopkins University

  Advanced Detection Methods and Discovery of New Botulinum Neurotoxins


Eric Johnson, ScD, University of Wisconsin, Madison
  Rapid and Sensitive Differential Detection of Pathogens


W. Ian Lipkin, MD, Columbia University
  Moderated Q&A and Wrap Up
Ian Lipkin, MD and all Session Speakers

3:00-5:00pm

Concurrent Session F6 – Influenza: 1918 and Beyond

Moderator: Kanta Subbarao, MBBS, MPH, NIAID, NIH

  Welcome and Opening Remarks

Kanta Subbarao, MBBS, MPH, NIAID, NIH

  Origin and Virulence of the 1918 Influenza Virus
Jeffrey Taubenberger, MD, PhD, Armed Forces Institute of Pathology

  Virus Infection and the Interferon Response: A Global View Through Functional Genomics


John Kash, PhD, University of Washington
  Pandemic Influenza Vaccines Kanta Subbarao, MBBS, MPH, NIAID, NIH

  Computational Modeling of Pandemic Influenza Control Strategies


Donald Burke, PhD, Johns Hopkins University School of Public Health
  Moderated Q&A and Wrap Up Kanta Subbarao, MBBS, MPH and all Session Speakers

Saturday, February 18, 2006
Time Session Presenters
8:30-11:30am

Plenary Session- Modulation of the Host Responses by Biodefense Agents

Organizer: Olaf Schneewind, MD, University of Chicago

  Plenary Keynote Address – Overview of the Innate Responses to Pathogens
Christine Biron, PhD, Brown University

  Identification and Characterization of Viral Antagonists of Type 1 Interferon Adolfo Garcia-Sastre, PhD, Mount Sinai School of Medicine

  Innate Immunity against Francisella tularensisis Dependent on the ASC/Caspase-1 Axis


Denise Monack, PhD, Stanford University
  Modulation of Innate Immunity by Yersinia pestis Olaf Schneewind, MD, University of Chicago

 

Intracellular Protein Therapy of Inflammation and Apoptosis Caused by Bioagents

Jack J. Hawiger, MD, PhD, Vanderbilt University School of Medicine